Rxsight Inc (RXST) - News Archive

Making Sense of Market Movements: Insights into RxSight s Recent Decline and What It Means for Shareholders In the intricate world of investment, keeping a vigilant eye on market shifts and company performances is param...

In recent weeks, shareholders of RxSight, Inc. (NASDAQ: RXST) have found themselves in a complex financial landscape as news of a securities class action has been announced. The Rosen Law Firm, a globally recognized fir...

Investors on Alert: Class Action Lawsuit Looms Over RxSight, Inc. The financial landscape can be perilous, and for investors of RxSight, Inc. (NASDAQ: RXST), those turbulent waters are presently more daunting. Pomerantz...

Investor Concerns Prompt Pomerantz Law Firm Investigation into RxSight, Inc. In a recent announcement, Pomerantz LLP, a prominent law firm specializing in securities litigation, has launched an investigation into potent...

RxSight, Inc. Enhances Tangible Leverage Ratio, Closing Successful Public Offering of Common StockAliso Viejo, Calif. - May 13, 2024 - RxSight, Inc. (Nasdaq: RXST), a leading ophthalmic medical device company specializi...

ALISO VIEJO, Calif., May 08, 2024 (NASDAQ: RXST) RxSight, Inc., a leading ophthalmic medical device company specializing in providing personalized vision solutions post cataract surgery, announced today the pricing of i...

RxSight, Inc. Aims to Raise $100 Million in Public Offering to Fuel Expansion and InnovationALISO VIEJO, Calif. - RxSight, Inc. (Nasdaq: RXST), a leading ophthalmic medical device company specializing in personalized vi...

RxSight, Inc., an industry-leading ophthalmic medical device firm committed to providing patients with customized vision after cataract surgery, announced the commercial availability of its most revolutionary product ye...

RxSight, Inc., a leading ophthalmic medical device company, has recently revealed their preliminary unaudited financial and operational results for the fourth quarter and full-year 2023. Additionally, the company provid...